Finance

Beta
Lists
605077:SHA
Zhejiang Huakang Pharmaceutical Co Ltd
CNÂ¥11.59
-3.01%
(-0.36) 1D
Jun 24, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605077...
Open
CNÂ¥12.07
High
CNÂ¥12.07
Low
CNÂ¥11.46
Mkt. cap
3.58B
Avg. vol.
15.93M
Volume
5.71M
Dividend
4.31%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 17, 2026
P/E ratio
24.91
52-wk high
CNÂ¥20.20
52-wk low
CNÂ¥11.27
EPS
CNÂ¥0.47
No. of employees
2K
Open
CNÂ¥12.07
High
CNÂ¥12.07
Low
CNÂ¥11.46
Mkt. cap
3.58B
Avg. vol.
15.93M
Volume
5.71M
Dividend
4.31%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 17, 2026
P/E ratio
24.91
52-wk high
CNÂ¥20.20
52-wk low
CNÂ¥11.27
EPS
CNÂ¥0.47
No. of employees
2K
News stories
From sources across the web
About Zhejiang Huakang Pharmaceutical Co Ltd
CEO-
Employees2.25K
FoundedJul 10, 2001
Headquarters-
SectorFood
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.05B
1.09B
1.23B
1.19B
Cost of goods sold
877.24M
952.06M
1.09B
1.05B
Cost of revenue
877.24M
952.06M
1.09B
1.05B
Research and development expenses
42.53M
35.69M
40.42M
38.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.78M
39.25M
39.76M
30.42M
Operating expense
91.87M
71.31M
89.35M
75.85M
Total operating expenses
969.10M
1.02B
1.18B
1.13B
Operating income
80.21M
69.79M
46.77M
59.31M
Other non operating income
-3.11M
4.01M
-4.80M
-6.63M
EBT including unusual items
61.26M
42.47M
33.00M
26.61M
EBT excluding unusual items
60.14M
46.24M
20.54M
34.61M
Income tax expense
7.75M
6.93M
887.80K
3.98M
Effective tax rate
12.65%
16.31%
2.69%
14.94%
Other operating expenses
255.31K
131.76K
9.18M
2.50M
Net income
52.67M
34.68M
31.92M
22.17M
Net profit margin
5.02%
3.17%
2.60%
1.87%
Earnings per share
-
-
-
-
Interest and investment income
6.64M
5.56M
7.52M
10.42M
Interest expense
-28.77M
-27.95M
-29.07M
-28.48M
Net interest expenses
-22.14M
-22.38M
-21.55M
-18.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
143.62M
119.62M
119.39M
131.92M
Gain or loss from assets sale
-73.98K
73.98K
-97.04K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more